EIR Document: Revance Therapeutics Inc, Jul 15, 2022

FDANews EIR Revance Therapeutics Inc Jul 15 2022 top
Virginia A. Carroll FDA Investigator Patricia F. Hughes Troost FDA Investigator Sarah A. Johnson FDA Investigator Hughes Troost, Patricia F FDA Investigator

Establishment Inspection Report for the FDA inspection at Revance Therapeutics Inc's Newark site on Jul 15, 2022. Get detailed insights.